They send us goodies. We have bracelets and stickers,” Moeller said. "The cool thing about it is they make you a website so we can take online donations.” Maya had lemonade, lemon cookies and lemon ...

The form of neuropathy may be further broken down by cause, or the size of predominant fiber involvement, i.e., large fiber or small fiber peripheral neuropathy.

A polymer-based device cleared by the FDA offers physicians a new way for repairing peripheral nerve injuries.

Neuropathy affects people of all ages, but primarily older adults. The most common and painful area affected are the hands and feet. Our friends with Essential Neuropathy are back discussing their ...

More information: Tamar Amishav et al, Peripheral information's effect on emotional intensity depends on depression level., Emotion (2025). DOI: 10.1037/emo0001538 ...

Boyd al. now reveal that a diet enriched in ω-6 polyunsaturated fatty acids (PUFAs) triggers peripheral neuropathy in mice, and this effect is reversed by a diet enriched in ω-3 PUFAs.

It is a place where patients with chronic conditions like neuropathy, fibromyalgia, shingles, post-herpetic neuralgia, Bell's Palsy, and chronic pain find more than just relief—they find healing.

Just over a year after its first phase 3 trial of its Engensis gene therapy for painful diabetic peripheral neuropathy (DPN) bombed, Helixmith has started dosing patients in a new study. The South ...

Diabetes mellitus is the most common cause of neuropathy worldwide. In this review, the clinical, pathological and therapeutic aspects of various forms of diabetic neuropathy are discussed.

Among patients with moderate peripheral artery disease, GLP-1 use was associated with reduced risk for cardiovascular and limb events and mortality, researchers reported at the Society for ...

Multifocal motor neuropathy (MMN) is a rare disease that causes slowly worsening muscle weakness, mainly in your hands, arms, and legs. It affects your body's motor nerves, which control your muscles.

On the heels of STRIDE, one of the first trials to show glucagon-like peptide-1 (GLP-1) receptor agonists can help patients with PAD, a retrospective study of more than 100,000 patients provides more ...